Skip to content

Brain Oxygenation During Prehospital Anesthesia

Brain Oxygenation During Prehospital Anesthesia: an Observational Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03948711
Acronym
BOPRA-P
Enrollment
100
Registered
2019-05-14
Start date
2019-05-20
Completion date
2020-09-30
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Brief summary

The study will evaluate the feasibility of Nonin SenSmart H500 device to measuring brain oxygenation during prehospital anesthesia of adult patient. The study also estimates the incidence of cerebral hypoxic events of anesthetized patients during prehospital care. The study does not affect the treatment of the patient. The study is pilot study and will be followed with a main study to assess the association between cerebral oxygenation during prehospital care and outcome of the patient.

Interventions

DEVICENear-infrared spectroscopy (NIRS) monitoring of cerebral oxygenation

Monitoring before anesthesia to hospital admission. No treatment decisions made based on monitoring.

Sponsors

Oulu University Hospital
CollaboratorOTHER
FinnHEMS
CollaboratorUNKNOWN
Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* sedation or anesthesia provided to facilitate endotracheal intubation, performed by HEMS team regardless of the reason

Exclusion criteria

* Cardiac arrest at the time of intubation * Physical barrier for NIRS measuring (e.g. forehead laceration) * HEMS physician does not escort patient to the hospital (and patient is not dead on the scene after inclusion) * Workload too high to ensure standard level of clinical care during the study * Known special vulnerability including known mental disability (permanent, not related to acute condition), patients in nursing homes, prisoners and forensic psychiatric patients. * Known or evident pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Disturbance-free time of the total monitoring timePrehospital phaseProportion of time with readable monitor signal of the total time monitor connected to the patient
Cerebral desaturation eventsDuring prehospital phase after induction of anesthesiaNumber of patients with forehead regional oxygen saturation ≤50% for ≥5 minutes

Secondary

MeasureTime frameDescription
Survival30 days, 12 monthsData from population registry center
On-scene timePrehospital phaseTime from arrival of helicopter emergency medical services unit on the patient to beginning of transportation
Health related quality of life12 monthstotal score of 15-D questionnaire including 15 dimensions each ranked from 1 (good quality of life) to 5 (poor quality of life)
Neurologic disability30 days, 12 months3-6 on modified Rankin scale (range from 0 \[no symptoms at all\] to 6 \[dead\], evaluated by trained research nurse
Qualitative feedback from HEMS crewsPrehospital phaseComments on the usability of the study device

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026